Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

¹⁹F (Perfluoropropane) MRI

NCT: NCT07305532 · NOT_YET_RECRUITING

NCT IDNCT07305532
StatusNOT_YET_RECRUITING
Start Date2026-05-20
Completion2030-12-30

Brief Summary

Healthy volunteers aged 18 to 85 will undergo ¹⁹F (perfluoropropane) MRI to support the development of imaging sequences, reconstruction algorithms, and hardware necessary for acquiring high-spatial resolution lung images. The study will also evaluate signal-to-noise ratio, contrast-to-noise ratio, spatial resolution, scan duration, and pulmonary gas exchange measurements derived from ¹⁹F (perfluoropropane) MRI.

Frequently Asked Questions

What is ¹⁹F (Perfluoropropane) MRI?

¹⁹F (Perfluoropropane) MRI is a clinical trial registered under NCT07305532. Current status: NOT_YET_RECRUITING.

What is the status of NCT07305532?

The current status of NCT07305532 (¹⁹F (Perfluoropropane) MRI) is: NOT_YET_RECRUITING.

When did ¹⁹F (Perfluoropropane) MRI start?

¹⁹F (Perfluoropropane) MRI started on 2026-05-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑